Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of brea

[News]

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

More... (http://www.news-medical.net/news/20100407/Study-demonstrates-potential-ability-of-Chronix-serum-DNA-assays-in-diagnosis-of-breast-cancer.aspx)